Drug Type Small molecule drug |
Synonyms INV 8989, INV8989 |
Target |
Action degraders |
Mechanism KRAS G12D degraders(GTPase KRas G12D degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| KRAS mutation-related tumors | IND Application | China | 26 Dec 2025 |





